Company Profile
Kenvue Stock Price, News & Catalysts
- Ticker:
- KVUE
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
17.22 USD (-2.49%)
Close
Last updated: October 1, 2026
33.3B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, KVUE closed down 2.49% at $17.22. No new same-company headline was identified in the current news window.
Company overview
Global Consumer Health Company
Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands. Its products are sold through pharmacies, mass merchants, grocery stores, e-commerce channels, and other retail outlets around the world.
Self Care Portfolio
The Self Care segment includes over-the-counter products for pain, allergy, digestive health, smoking cessation, and cough, cold, and flu. Major brands include Tylenol, Zyrtec, Pepcid, and Nicorette, supported by consumer marketing and healthcare-professional recognition.
Skin Health and Beauty
Skin Health and Beauty includes brands such as Neutrogena, Aveeno, and OGX. The business competes through dermatological positioning, product renovation, digital marketing, and new formulations across facial care, sun care, body care, and hair care.
Essential Health Brands
Essential Health covers oral care, wound care, baby care, and women's health. Listerine, Band-Aid, Johnson's, Stayfree, and related brands provide recurring demand across everyday categories and give Kenvue broad retail distribution.
Brand-Led Innovation Model
Kenvue combines established household brands with formulation, packaging, and claims innovation. Recent activity includes new Neutrogena and OGX products, Listerine formats, wound-care products, and an FDA-approved fixed-dose Tylenol and naproxen combination.
Future catalysts
- U.S. retail launch of Tylenol with Naproxen following FDA approval.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kenvue (KVUE)?
Kenvue (KVUE) most recently closed at 17.22 USD, a -2.49% move versus the previous session.
What is the market cap of Kenvue (KVUE)?
Kenvue currently has a market capitalization of 33.3B USD on BioPharmSignal.
What does Kenvue do?
Global Consumer Health Company Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands. Its products are sold through pharmacies, mass merchants, grocery stores, e-commerce channels, and other retail outlets around the world. Self Care Portfolio The Self Care segment includes...
On which exchange is KVUE stock listed?
Kenvue (KVUE) is associated with NYSE, United States, Biopharma.
What is Global?
Global Consumer Health Company Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands.
Which conditions is Kenvue targeting with Global?
Global Consumer Health Company Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands. Its products are sold through pharmacies, mass merchants, grocery stores, e-commerce channels, and other retail outlets around the world. Self Care Portfolio The Self Care segment includes...
How does Kenvue describe recent progress with Global?
U.S. retail launch of Tylenol with Naproxen following FDA approval.
What is Consumer?
Global Consumer Health Company Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands.